placebocontrolled trial cephalexin therapy ambulatory management patient cystic fibrosis effect oral administration cephalexin evaluated doubleblind placebocontrolled crossover study 17 patient mild moderate pulmonary disease due cystic fibrosis two year fourmonth period cephalexin alternated fourmonth placebo period thus patient served control subject fungal vulvovaginitis occurred two patient cephalexin therapy 2 year study rate colonization mucoid strain pseudomonas aeruginosa increased disease severity deteriorated patient initially colonized p aeruginosa shortterm course sputum culturespecific antibiotic improved course patient mild moderate pulmonary disease due cystic fibrosis treatment cephalexin decreased frequency respiratory illness respiratory illness requiring antibiotic hospitalization respiratory illness patient initially colonized staphylococcus aureus andor haemophilus influenzae also reduced colonization organism improved weight gain 16 17 patient associated period cephalexin therapy pulmonary function test remained stable improved 10 14 patient disease severity improved patient colonized p aeruginosa